PDF(1370 KB)
PDF(1370 KB)
PDF(1370 KB)
儿童肺炎支原体肺炎合并外周血淋巴细胞计数减少的临床分析
Clinical features of children with Mycoplasma pneumoniae pneumonia and peripheral lymphocytopenia
目的 探讨儿童肺炎支原体肺炎（MPP）合并外周血淋巴细胞计数减少的临床特征。方法 纳入2018年6月至2019年6月进行支气管肺泡灌洗的MPP住院患儿310例作为研究对象，包括单纯MPP患儿241例（未合并外周血淋巴细胞减少），MPP合并外周血淋巴细胞减少患儿69例，比较两组患儿临床资料及治疗转归。结果 与单纯MPP组比较，MPP合并淋巴细胞计数减少组的热程和住院时间均较长，C反应蛋白、乳酸脱氢酶、支气管肺泡灌洗液中肺炎支原体DNA拷贝数值均显著升高（P < 0.05）。MPP合并淋巴细胞计数减少组肺实变、肺外并发症、支气管镜下严重病变（糜烂/痰栓）及重症MPP病例的发生率均明显高于单纯MPP组（P < 0.05）。结论 MPP合并外周血淋巴细胞计数减少患儿存在更严重的免疫损伤；外周血淋巴细胞数量可在一定程度上反映MPP的严重程度。
Objective To study the clinical features of children with Mycoplasma pneumoniae pneumonia (MPP) and peripheral lymphocytopenia. Methods A total of 310 MPP children who were hospitalized and underwent bronchoalveolar lavage from June 2018 to June 2019 were enrolled and divided into two groups: simple MPP group with 241 children (without peripheral lymphocytopenia) and MPP + peripheral lymphocytopenia group with 69 children. The two groups were compared in terms of clinical data and treatment outcome. Results Compared with the simple MPP group, the MPP + peripheral lymphocytopenia group had significantly longer duration of fever and length of hospital stay and significant increases in C-reactive protein, lactate dehydrogenase, and Mycoplasma pneumoniae DNA copies in bronchoalveolar lavage fluid (P < 0.05). Compared with the simple MPP group, the MPP + peripheral lymphocytopenia group had significantly higher incidence rates of intrapulmonary consolidation, extrapulmonary complications, and serious lesions under bronchoscopy (erosion or sputum bolt) and a significantly higher proportion of patients with severe MPP (P < 0.05). Conclusions Children with MPP and peripheral lymphocytopenia tend to have more severe immunologic injury. Peripheral blood lymphocyte count may be used to evaluate the severity of MPP.
[1] Leung AKC, Wong AHC, Hon KL. Community-acquired pneumonia in children[J]. Recent Pat Inflamm Allergy Drug Discov, 2018, 12(2):136-144.
[2] Bajantri B, Venkatram S, Diaz-Fuentes G. Mycoplasma pneumoniae:a potentially severe infection[J]. J Clin Med Res, 2018, 10(7):535-544.
[3] Saraya T, Kurai D, Nakagaki K, et al. Novel aspects on the pathogenesis of Mycoplasma pneumoniae pneumonia and therapeutic implications[J]. Front Microbiol, 2014, 5:410.
[4] Guo L, Liu F, Lu MP, et al. Increased T cell activation in BALF from children with Mycoplasma pneumoniae pneumonia[J]. Pediatr Pulmonol, 2015, 50(8):814-819.
[5] 中华医学会儿科学分会呼吸学组, 《 中华儿科杂志》 编辑委员会. 儿童社区获得性肺炎管理指南(2013修订)(上)[J]. 中华儿科杂志, 2013, 51(10):745-752.
[6] 李影林. 中华医学检验全书(上卷)[M]. 北京:人民卫生出版社, 1996:200-201.
[7] Saraya T. Mycoplasma pneumoniae infection:basics[J]. J Gen Fam Med, 2017, 18(3):118-125.
[8] Bodhankar S, Sun X, Woolard MD, et al. Interferon gamma and interleukin 4 have contrasting effects on immunopathology and the development of protective adaptive immunity against Mycoplasma respiratory disease[J]. J Infect Dis, 2010, 202(1):39-51.
[9] 李娜, 穆亚平, 陈静, 等. 淋巴细胞亚群绝对计数对儿童难治性肺炎支原体肺炎的早期预测作用[J]. 中国当代儿科杂志, 2019, 21(6):511-516.
[10] Bajantri B, Toolsie O, Venkatram S, et al. Mycoplasma pneumoniae pneumonia:walking pneumonia can cripple the susceptible[J]. J Clin Med Res, 2018, 10(12):891-897.
[11] Obirikorang C, Quaye L, Acheampong I. Total lymphocyte count as a surrogate marker for CD4 count in resource-limited settings[J]. BMC Infect Dis, 2012, 12:128.
[12] Stebbing J, Sawleshwarkar S, Michailidis C, et al. Assessment of the efficacy of total lymphocyte counts as predictors of AIDS defining infections in HIV-1 infected people[J]. Postgrad Med J, 2005, 81(959):586-588.
[13] Zhang Y, Mei S, Zhou Y, et al. Cytokines as the good predictors of refractory Mycoplasma pneumoniae pneumonia in schoolaged children[J]. Sci Rep, 2016, 6:37037.
[14] Jeong JE, Soh JE, Kwak JH, et al. Increased procalcitonin level is a risk factor for prolonged fever in children with Mycoplasma pneumonia[J]. Korean J Pediatr, 2018, 61(8):258-263.
[15] 刘金荣, 彭芸, 杨海明, 等. 难治性肺炎支原体肺炎的表现特征和判断指标探讨[J]. 中华儿科杂志, 2012, 50(12):915-918.
湖南省人民医院仁术基金项目（2016-2-18）。
